infectious diseases family medicine board review 2016 · · 2016-04-13infectious diseases family...
TRANSCRIPT
Infectious Diseases Family Medicine
Board Review 2016
Brian Schwartz, MD
UCSF, Division of Infectious Diseases
Case 1
32 y/o M with 3 days of an enlarging, painful lesion on his L thigh that he attributes to a “spider bite”
T 36.9 BP 118/70 P 82
How would you manage this patient?
A. Incision and drainage alone
B. Incision and drainage plus cephalexin
C. Incision and drainage plus TMP-SMX
Incis
ion an
d dra
inage
alo
ne
Incis
ion an
d dra
inage
plu
...
Incis
ion an
d dra
inage
pl..
59%
33%
9%
Abscesses: Do antibiotics provide benefit over I&D alone?
0%
20%
40%
60%
80%
100%
Rajendran '07 Duong '09 Schmitz '10
% p
atie
nts
cu
red
Placebo
Antibiotic
p=.25 p=.12 p=.52
Cephalexin TMP-SMX TMP-SMX
1Rajendran AAC 2007; 2Schmitz G Ann Emerg Med 2010; 3Duong Ann Emerg Med 2009
Antibiotic therapy is recommended for abscesses associated with:
• Severe disease, rapidly progressive with associated cellulitis or septic phlebitis
• Signs or symptoms of systemic illness
• Associated comorbidities, immunosuppressed
• Extremes of age
• Difficult to drain area (face, hand, genitalia)
• Failure of prior I&D Liu C. Clin Infect Dis. 2011
Microbiology of Purulent SSTIs
MRSA 59%
MSSA 17%
B-hemolytic strep 3%
non-B hemolytic strep 4% other
8%
unknown 9%
Moran NEJM 2006
Empiric PO Antibiotics for Purulent SSTIs Strep active
Dosing Comments
PO agents
TMP-SMX +/- Q12h HyperK+
Doxy/mino +/- Q12h GI; Photosensitivity
Clindamycin ++ Q8h Susceptible: Adults 50%; Peds 75%
Linezolid ++ Q12h $$$; Tox - heme, SSRI
Empiric IV Antibiotics for Purulent SSTIs
Dosing Comments
Vancomycin Q12h OK for bacteremia, PNA
Daptomycin Q24h OK for bacteremia, not PNA
Televancin Q24h Approved for PNA, renal tox
Ceftaroline Q12h Active vs. Gram - (not pseudo)
Dalbavancin Q7d x 2
Oritavancin x1 VRE activity
*Linezolid and tedizolid come in IV formulation as well
How would you manage this patient?
A. Incision and drainage alone
B. Incision and drainage plus cephalexin
C. Incision and drainage plus TMP-SMX
Case 2 28 y/o woman presents with erythema of her left foot over past 48 hrs
No purulent drainage, exudate , or fluctuance.
T 37.0 BP 132/70 P 78
Eels SJ et al Epidemiology and Infection 2010
How would you manage this patient?
A. Clindamycin 300 mg TID
B. Cephalexin 500 mg QID, monitor clinically with addition of TMP/SMX if no response
C. Cephalexin 500 mg QID + TMP/ SMX 1 DS BID
Clindam
ycin 3
00 mg T
ID
Cephalexin
500 m
g QID
,...
Cephalexin
500 m
g QID
...
17%25%
58%
Cephalexin vs. Cephalexin + TMP-SMX in patients with Uncomplicated Cellulitis
82.0%
6.8%
53.0%
85.0%
6.8%
49.0%
0.0%
20.0%
40.0%
60.0%
80.0%
100.0%
Cure Progression toabscess
Adverse Events
Cephalexin
Cephalexin +TMP-SMX
Pallin CID 2013; 56: 1754-1762
N=146
Empiric Antibiotics for Non-purulent SSTIs
MSSA active
MRSA active
Dosing
PO
Penicillin - Q6h
Cephalexin + Q6h
Dicloxacillin + Q6h
Clindamycin ++ + Q8h
IV
Penicillin - Q6h
Cefazolin + Q8h
Ceftriaxone + Q24h
How would you manage this patient?
A. Clindamycin 300 mg TID
B. Cephalexin 500 mg QID, monitor clinically with addition of TMP/SMX if no response
C. Cephalexin 500 mg QID + TMP/ SMX 1 DS BID
Case 3: A slight alteration…
• 34 y/o comes in with the similar symptoms
• Temp 38.9, HR 105, SBP 100, RR 20
• Appears ill and in more pain than what you would expect for cellulitis
Necrotizing soft tissue infections: clinical clues
Wong CH. Jour of Bone and Joint Surg. 2003
0
10
20
30
40
50
60
70
80
90
100
% o
f p
atie
nts
Late findings
Necrotizing soft tissue infections: radiographic techniques
• Plain films
– Low sensitivity
– Helpful if gas present
• CT and ultrasound
– May identify other Dx (abscess)
• MRI
– Enhanced sensitivity, low specificity
Necrotizing Skin and Soft Tissue Infection: Pathogens
Monomicrobial Polymicrobial
Group A strep
CA-MRSA
Clostridia sp
Gram negatives
Vibrio vulnificus
Aerobic Gram +/Gram - PLUS
Anaerobes
Wong CH. J Bone and Joint Surg. 2003
Empiric treatment of necrotizing soft tissue infections
• Early surgical intervention! (be annoying)
• Antimicrobial therapy
–Pip/tazo (Gram neg/anaerobes)
plus
–Vancomycin (MRSA)
plus
–Clindamycin (group A strep)
Toxic shock syndromes
Pathophys Site Clinical Rx
Strep (GAS)
Pyrogenic exotoxin
(superantigen)
Sterile (blood, tissue)
Shock •Prot synth inhibitor •IVIg
Staph TSST-1 (superantigen)
Non-sterile site often (tampon,
nasal packing)
Shock + Eythroderma
(desquamation (1-2 weeks later)
•Prot synth inhibitor
Case
• 61 y/o diabetic presents to ED with, fever, stiff neck, and new onset seizure.
• Febrile to 39°C with stable vital signs.
• Lethargic but able to answer questions.
• Nuchal rigidity and photophobia seen but no focal neurological abnormalities.
Who needs a head CT before LP? Who is at high risk for herniation from LP?
• Patients at high risk for mass lesions or increased intracranial pressure can be identified clinically and should then undergo CT scan
• Who are high risk patients? – New-onset seizure – Immunocompromised – Focal neurological finding – Papilledema – Moderate-severe impairment of consciousness
Hasbun R. NEJM. 2001. Gopal AK. Arch Int Med. 1999.
Question: Which is the preferred antibiotic regimen for this patient?
(61 y/o male)
A. Ceftriaxone
B. Ceftriaxone and Vancomycin
C. Ceftriaxone and Ampicillin
D. Vancomycin and Ceftriaxone and Ampicillin
Ceftria
xone
Ceftria
xone a
nd Vanco
...
Ceftria
xone a
nd Am
picilli
n
Vancom
ycin an
d Ceftr
ia...
0%
62%
6%
32%
Empiric antimicrobial therapy Risk factor Pathogens Antimicrobials
< 1 month GBS, E. coli, L. monocytogenes
Ampicillin + cefotaxime
1-23 months S. pneumoniae, N. meningitidis, H. influenzae
Vancomycin + 3rd gen ceph
2-50 yrs N. meningitidis, S. pneumoniae
Vancomycin + 3rd gen ceph
> 50 yrs S. pneumoniae, N. meningitidis, L. monocytogenes
Vancomycin+ 3rd gen ceph + ampicillin
Adapted from Tunkel AR. CID 2004; GBS=group B strep (Strep agalactiae), 3rd gen ceph=ceftriaxone or cefotaxime
IDSA algorithm for management of bacterial meningitis
Indication for head CT YES NO
Blood cx + Lumbar puncture Blood cx
Steroids and empiric antimicrobials
Steroids and empiric antimicrobials
CSF suggestive of bacterial meningitis
Head CT w/o mass lesion or herniation
Lumbar puncture Refine therapy
Tunkel AR. CID 2004
Question: Which is the preferred antibiotic regimen for this patient?
(61 y/o male)
A. Ceftriaxone
B. Ceftriaxone and Vancomycin
C. Ceftriaxone and Ampicillin
D. Vancomycin and Ceftriaxone and Ampicillin
Antibiotic prophylaxis for contacts?
• Only those with close contact to case of Neisseria or Haemophilus
• Prophylaxis options
– Ciprofloxacin
– Rifampin
– Ceftriaxone
HSV infections of CNS
• Aseptic meningitis (HSV-2) – Benign course
– Treatment of unclear benefit, IV->PO acyclovir
– May recur (Mollaret's syndrome)
• Encephalitis (HSV-1) – Severe neurologic impairment
– Classical MRI changes (temporal lobes)
– Start treatment when you suspect diagnosis
– Treatment - IV acyclovir (10 mg/kg IV q8)
West Nile virus
80% ASYMPTOMATIC
20%
WEST NILE FEVER
< 1% NEUROINVASIVE DISEASE
•Encephalitis (55-60%)
•Meningitis (35-40%)
•Poliomyelitis (5-10%)
WNV Fever
•Fever and HA
•Malaise/Fatigue
•Anorexia
Peterson LR. JAMA. 2004
Diagnosis: WNV IgM and IgG from serum and CSF
Case
• 65 y/o diabetic woman presents to clinic for routine evaluation. She has been feeling well. A urinalysis and culture are sent.
• UA: WBC->100, RBC-0, Protein-300
• The next day you are called because the urine culture has >100,000 Klebsiella pneumoniae
Question 5: What do you recommend?
A. No antibiotics
B. Empiric ciprofloxacin and await susceptibilities
C. Repeat culture in 1 week and if bacteria still present then treat
No antib
iotic
s
Empiri
c cip
roflo
xacin an...
Repeat cultu
re in
1 w
eek...
62%
7%
31%
Definition: Asymptomatic bacteriuria
• Bacteriuria without symptoms
– Midstream: ≥105 CFU/ml
– Cath: ≥102 CFU/ml
• Pyuria is present > 50% of patients
Asymptomatic bacteriuria in diabetic women
• Asymptomatic bacteriuria ~ 25% of diabetic women (pyuria is usually present)
• RCT, placebo controlled of 105 diabetic women
• 14 days of antibiotic vs. placebo
• 1° endpoint: symptomatic UTI
– 42% antibiotic group vs. 40% placebo
– RR 1.19 (0.28–1.81),p=0.42 Harding GKM. NEJM 2003
Treatment of asymptomatic bacteriuria?
• Clear benefit
– Pregnant women
– Pre traumatic urologic interventions with mucosal bleeding
• Likely benefit
– neutropenic
• No benefit
– Postmenopausal ambulatory women
– Institutionalized
– Spinal cord injuries
– Patients with urinary catheters
– Diabetics
Question 5: What do you recommend?
A. No antibiotics
B. Empiric ciprofloxacin and await susceptibilities
C. Repeat culture in 1 week and if bacteria still
present then treat
Case 6
• A 21 year-old college student, calls to say that she has “a urinary tract infection, again”
• You have treated her for uncomplicated cystitis 2 times in the past year
• You obtain a UA:
– Leukocyte esterase 3+, RBC 1+
Question 6: According to the Infectious Diseases Society of America Guidelines (2011 last update) - what is the 1st line treatment for an uncomplicated UTI?
A. Ciprofloxacin 250mg BID x 3d
B. Nitrofurantoin 100mg BID x 5d
C. TMP-SMX DS BID x 7d
D. Cephalexin 500 mg QID x 7d
Cipro
floxa
cin 2
50mg B
ID..
Nitrofu
ranto
in 1
00mg B
I...
TMP-S
MX D
S BID
x 7d
Cephalexin
500 m
g QID
x 7d
43%
6%4%
47%
IDSA guidelines for uncomplicated UTI treatment
Goal: Low resistance and low “collateral damage”
• Nitrofurantoin 100 mg PO BID x 5 days
• TMP-SMX DS PO BID x 3 days
– avoid if resistance >20%, recent usage
• Fosfomycin 3 gm PO x 2
Gupta K. CID 2011
Question 6: According to the Infectious Diseases Society of America Guidelines (2011 last update) - what is the 1st line treatment for an uncomplicated UTI?
A. Ciprofloxacin 250mg BID x 3d
B. Nitrofurantoin 100mg BID x 5d
C. TMP-SMX DS BID x 7d
D. Cephalexin 500 mg QID x 7d
What would make the UTI “complicated?”
• Anatomic abnormality
• Indwelling catheter
• Recent instrumentation
• Men
• Healthcare-associated
• Recent antimicrobial use
• Symptoms > 7 days
• Diabetes or immunosuppression
• History of childhood UTI
How would you treat?
– Fluoroquinolones for empiric therapy
– Obtain cultures
– Duration 7-14 days
Prevention of recurrent UTIs
• Prevent vaginal colonization w/ uropathogens
– Avoid spermicide
– Intra-vaginal estrogen (post-menopausal)
• Prevent growth of uropathogens in bladder
– Methenamine hippurate
– Cranberry juice
– Postcoitol or daily antibiotics
• Correct anatomic/neurologic problems
– Select cases consider urology evaluation (elevated Cr, hematuria, recurrent proteus infection)
Question: If this same patient presented with pyelonephritis what
would be the best regimen?
A. Ceftriaxone 1 gm IV q24
B. Moxifloxacin 400 mg IV/PO q24
C. Nitrofurantoin 100 mg PO q12
D. Cefpodoxime 200 mg PO q12
Ceftria
xone 1
gm IV
q24
Moxif
loxa
cin 4
00 mg I
V/..
Nitrofu
ranto
in 1
00 mg P
...
Cefpodoxim
e 200 m
g PO...
70%
9%2%
20%
Empiric treatment of pyelonephritis
• Recommended
– Ciprofloxacin 500 mg q12 (7 days if uncomplicated) • Levofloxacin OK but not Moxifloxacin
– Ceftriaxone 1 gm IV q24 (14 days)
• Not recommended
– TMP-SMX (high resistance rate so not good empiric)
– Nitrofurantoin (does not get into kidney parenchyma)
• Health-care associated pyelonephritis – Use antipseudomonal agent other than fluoroquinolone
Question: If this same patient presented with pyelonephritis what
would be the best regimen?
A. Ceftriaxone 1 gm IV q24
B. Moxifloxacin 400 mg IV/PO q24
C. Nitrofurantoin 100 mg PO q12
D. Cefpodoxime 200 mg PO q12
Case
• 60 y/o woman with HTN presents with 3 days of cough with green sputum, dyspnea on exertion, fever, pleuritic chest pain. She otherwise has no past medical history.
• Exam: 38.5°, 145/90, 100, 18, 95% RA •
• Chest: crackles at left base
• WBC: 15.5 CXR: LLL infiltrate
Question: How would you manage this patient?
A. Oral antibiotics at home
B. Hospitalize for IV antibiotics; when afebrile, switch to PO antibiotics and discharge home
C. Hospitalize for IV antibiotics; when afebrile, switch to PO antibiotics and discharge after 24 hours observation
D. Hospitalize for minimum of 7 days of IV antibiotics
Oral a
ntibio
tics a
t hom
e
Hospita
lize fo
r IV antib
iot..
.
Hospita
lize fo
r IV antib
iot..
.
Hospita
lize fo
r min
imum
..
84%
0%11%
5%
Pneumonia Severity Index
Demographic
Age (+1 point/yr, -10 if woman)
Nursing home (+10)
Comorbidities Cancer (+30)
Liver disease (+20)
CHF (+10)
Cerebrovascular dz (+10)
Renal disease (+10)
Examination Mental status (+20)
Pulse > 125 (+20)
Resp rate > 30 (+20)
SBP < 90 (+15)
Temp < 35 or > 40 (+10)
Labs pH < 7.35 (+30)
BUN > 30 (+20)
Na < 130 (+20)
Glucose > 250 (+10)
p02 < 60 (+10)
Hct < 30 (+10)
Pleural effusion (+10)
Don’t memorize this!
Pneumonia Severity Index http://pda.ahrq.gov/clinic/psi/psicalc.asp
Class PSI score Mortality Triage
I Age < 50, no comorbidity, stable vital signs
0.1% outpatient
II ≤ 70 0.7% outpatient
III 71-90 3% consider admission
IV 91-130 8% admission
V > 130 29% ? ICU
CAP: When to Admit
Outpatient: – Younger
– No cancer or end-organ disease
– No severe vital sign abnormalities
– No severe laboratory abnormalities
Inpatient:
– Doesn’t meet outpt criteria
– Hypoxia
– Active coexisting condition
– Unable to take oral meds
– Psychosocial issues
• Homeless, drug abuse, risk of non-adherence
CAP: When to Discharge
• Afebrile, hemodynamically stable, not hypoxic, and tolerating POs
• No minimum duration of IV therapy needed
• No need to watch on oral antibiotics
• Most patients with CAP, 7 days of antibiotic treatment is adequate
Question: How would you manage this patient?
A. Oral antibiotics at home
B. Hospitalize for IV antibiotics; when afebrile, switch to PO antibiotics and discharge home
C. Hospitalize for IV antibiotics; when afebrile, switch to PO antibiotics and discharge after 24 hours observation
D. Hospitalize for minimum of 7 days of IV antibiotics
Case:
• 82 y/o with h/o CHF presents with 5 days of productive cough and dyspnea. Denies recent travel or hospitalization.
• 39° 110/90 110 24 85% RA
• Chest: crackles at right base
• CXR: Right lower & middle lobe infiltrates
• Labs: WBC 12, BUN=38, otherwise normal
Question: What is the most appropriate treatment?
A. Cefuroxime IV
B. Levofloxacin IV
C. Piperacillin-tazobactam IV
D. Azithromycin IV
E. Cefepime IV + vancomycin IV
Cefuro
xime IV
Levo
floxa
cin IV
Pipera
cillin
-tazo
bacta
m IV
Azithro
mycin
IV
Cefepim
e IV + va
ncom
yc..
6%
54%
23%
0%
17%
Etiology of CAP
• Clinical and CXR not predictive of organism – Streptococcus pneumoniae
– Haemophilus influenzae
– Mycoplasma pneumoniae
– Chlamydophila pneumoniae
– Legionella
– (Enteric Gram negative rods)
– Viruses
– Staphylococcus aureus
Covered by
usual regimes
Not covered by
usual regimens
Empirical Treatment for Outpatients
No comorbidity or recent antibiotics
• Macrolide or
• Doxycycline
Comorbid condition(s)
age > 65, EtOH, CHF, severe liver or renal disease, cancer
or
Antibiotics in last 3 months
-lactam (e.g. amox) + either macrolide or doxycycline
or
• Respiratory FQ*
B-lactam= High-dose amoxicillin [e.g., 1 g 3 times daily] or amoxicillin-
clavulanate [2 g 2 times daily] is preferred; alternatives include ceftriaxone,
cefpodoxime, and cefuroxime [500 mg 2 times daily];
* Respiratory FQ = Levofloxacin or Moxifloxacin
Empirical Treatment for Inpatients
Inpatient
non-ICU
-lactam + macrolide or doxycycline or
• Respiratory FQ
Inpatient ICU -lactam + azithromycin or resp FQ
(Penicillin allergy: fluoroquinolone + aztreonam)
MRSA concern • Add vancomycin or linezolid to above
B-lactam = cefotaxime, ceftriaxone, and ampicillin-sulbactam;
ertapenem for selected patients
* Resp FQ = Levofloxacin or Moxifloxacin
Question: What is the most appropriate treatment?
A. Cefuroxime IV
B. Levofloxacin IV
C. Piperacillin-tazobactam IV
D. Azithromycin IV
E. Cefepime IV + vancomycin IV
Diagnostic Testing in CAP
• Chest radiography:
– Indicated for all patients with suspected pneumonia
• Blood culture:
– Recommended for inpatients (do before antibiotics)
• Sputum exam:
– Controversial but recommended for inpatients
• Other:
– Legionella urinary Ag, pnuemo urinary Ag, resp virus testing
Case
• 60 y/o intubated 17 days ago following MVA. Received ciprofloxacin for a UTI 8 days ago.
• Now she has new fever, WBC 15, and increased oxygen requirements.
• Chest X-ray was done
Question: Which antibiotics would you start after obtaining blood and sputum
cultures? A. Vancomycin
B. Vancomycin + ceftriaxone
C. Ceftriaxone + azithromycin
D. Vancomycin + meropenem
E. Moxifloxacin
Vancom
ycin
Vancom
ycin +
ceftr
iaxo
ne
Ceftria
xone +
azithro
mycin
Vancom
ycin +
mero
penem
Moxif
loxa
cin
2%
47%
0%
42%
9%
Ventilator associated pneumonia (VAP)
• Clinical diagnosis!
– Increased oxygen requirement
– Fever
– Increased WBC count
–New infiltrate on CXR
– Increased secretions
• Use respiratory culture to tailor therapy
HAP/VAP pathogens Empiric Treatment
Gram negatives -Pseudomonas -Acinetobacter -Enterics
Anti-pseudomonal cephalosporin (ceftaz or cefepime)
or
Anti-pseudomonal penicillin (piperacillin-tazobactam)
or
Anti-pseudomonal carbapenem (imi-, mero-, doripenem)
PLUS
Anti-pseudomonal aminogylcoside (gent, tobra, amikacin)
or
Anti-pseudomonal fluoroquinolone (cipro, levo)
PLUS
S. aureus (MRSA) Vancomycin or linezolid
When do we need to cover for pseudomonas?
• Not cause of community acquired pneumonia but if any below present can consider…
Recent or current hospitalization
Recent antibiotics
Structural lung disease (CF)
What antibiotics cover pseudomonas?
• B-lactams – Piperacillin and ticaricillin – Ceftazidime, cefepime – Aztreonam – Imipenem, meropenem, doripenem (not ertapenem)
• Fluoroquinolones – ciprofloxacin and levofloxacin (not moxifloxacin)
• Aminoglycosides – gentamicin, tobramycin, amikacin
Question: Which antibiotics would you start after obtaining blood and sputum
cultures? A. Vancomycin
B. Vancomycin + ceftriaxone
C. Ceftriaxone + azithromycin
D. Vancomycin + meropenem
E. Moxifloxacin
Case:
• 70 y/o M is hospitalized for diverticulitis. HD#9 he develops a new fever. Purulent drainage is noted from a central venous catheter, and it is removed.
• Fever persists for several days. Exam reveals new systolic murmur. Echo shows a small vegetation on the mitral valve.
• Which organism MOST LIKELY grew from his blood cultures?
Question:
A. Staphylococcus aureus
B. Streptococcus bovis
C. Enterococcus spp.
D. Candida
Staphylo
cocc
us aure
us
Strepto
cocc
us bovis
Entero
cocc
us spp.
Candida
64%
2%
18%16%
Endocarditis
• Most common organisms
– Staphylococcus aureus
– Streptococci, viridans group; also S. bovis
– Coagulase-negative staph (prosthetic valve)
– Candida
– Culture negative
– HACEK
Endocarditis: Modified Duke Criteria
• Diagnosis: Clinical Criteria
–Major • Blood culture criteria
• Endocardial involvement (Echo veg, new regurgitation)
–Minor • Predisposition Vascular phenomena
• Fever Immunologic phenomena
• Other microbiologic
Osler nodes Janeway lesions
Splinter hemorrhages
Roth spots (white-centered
retinal hemorrhages -
arrow heads)
Endocarditis
• Duke criteria continued…
–Definite endocarditis:
• 2 major OR 1 major + 3 minor OR 5 minor
– Indications for surgery?
• CHF, continued emboli, uncontrolled sepsis, perivalvular abscess
• Difficult to treat organisms (fungi, Gram- negatives, resistant organisms)
• Large vegetations (> 1 cm?)
Endocarditis - Treatment
• Penicillin-susceptible streptococcus
– Penicillin G or ceftriaxone x 4 wk
– Penicillin G or ceftriaxone + gentamicin x 2 wk
• Streptococcus MIC >0.1 to 0.5 mg/mL
– Penicillin G or ceftriaxone x 4 wk + gentamcin x 2 wk
• Streptococcus MIC >0.5 mg/mL or enterococcus
– Ampicillin or penicillin G + gentamicin x 4-6 wk
Use recommended regimens!
Endocarditis - Treatment
• Aortic or mitral valve MSSA
–Nafcillin or cefazolin x 6 wk
• MRSA
–Vancomycin x 6 wk
• HACEK
–Ceftriaxone x 4 wk
Endocarditis - Prophylaxis
• Prophylaxis only for highest risk patients
– Prosthetic valve, previous endocarditis, cardiac transplantation with valvulopathy, certain congenital heart disease
• Procedures requiring prophylaxis for above:
– Dental with manipulation of gingiva or periapical region of teeth or perforation of oral mucosa
– No prophylaxis for GI or GU procedures
Recommended antibiotics when endocarditis prophylaxis is needed
Oral Amoxicillin 2 g 1 hour pre-procedure
Penicillin allergy
Clindamycin 600 mg 1 hour pre-procedure or
Cephalexin 2 g 1 hour pre-procedure
or
Azithromycin or clarithromycin
500 mg 1 hour pre-procedure
Parenteral Ampicillin 2 g IM or IV 30 min pre-procedure
Penicillin allergy
Clindamycin 600 mg IV 1 hour pre-procedure or
Cefazolin 1 g IM or IV 30 min pre-procedure
Case
• 67 year-old male with COPD/asthma, presents to clinic with 3 days of fever, cough, wheezing, and achiness. You do a rapid flu test which is positive.
• How should you treat this patient?
Question
A. Start amantadine
B. Start oseltamivir
C. Start zanamivir
D. No treatment because symptoms > 48h
Start
amanta
dine
Start
oselta
miv
ir
Start
zanam
ivir
No treatm
ent beca
use s.
..
2%
51%
0%
47%
Influenza
• Two important types: A and B
• Influenza A
– Typed by glycoproteins: hemagglutinin/neuraminidase
– Treatments: • Adamantanes (amantadine, ramantidine)
• Neuraminidase inhibitors (oseltamivir, zanamivir)
• Influenza B: not susceptible to adamantanes
Influenza
• Diagnosis (sensitivity):
– PCR>>DFA (immunofluorescence)>Rapid test
• Treatment:
– Who
• Hospitalized or severe illness: anytime
• Outpt high-risk for complications: anytime
• Non-high-risk outpatients: < 48h of symptoms
– What
• Oseltamivir or Zanamivir
Question
A. Start amantadine
B. Start oseltamivir
C. Start zanamivir
D. No treatment because symptoms > 48h
Influenza Vaccine
• Recommended for everyone > 6 mo.
• Options
– Inactivated vaccines: > 6 months
– Live-attenuated: 2-49 years
Infection Control
Type of
Precaution
Conditions Examples
Contact
Diarrhea
Wounds
Vesicular rashes
Some resp infections
C. difficile,
chickenpox, smallpox,
scabies, lice, viral
conjunctivitis, drug
resistant organisms
Droplet Meningitis, seasonal
resp viruses
Meningococcus,
Pertussis, influenza
Airborne Some resp infections TB, chickenpox,
measles, smallpox,
SARS
High yield • Device (and line) related infections
– Answer usually “pull the line” plus antibiotics
• Endocarditis
– Acute: S. aureus (MRSA) #1
– Subacute: Viridans group streptococci #1
– Prosthetic valve endocarditis: S. aureus or S. epidermidis
• Doxycycline is usually the answer for…
– Lyme disease (also amoxicillin, ceftriaxone)
– Rocky mountain spotted fever (even in children)
– Ehrlichiosis and Anaplasmosis (“spotless fevers”)
– Syphilis (when penicillin is not an option but not neuro dz)
High yield
• Fungal infections
– Candidemia
• Empiric treatment for critically ill is an echinocandin
• Always remove central venous catheters
• Always get an eye exam to rule-out ocular involvement
– Histoplasmosis – itraconazole or ampho
– Coccidiomycosis – fluconazole or ampho
– Aspergillosis – voriconazole > ampho
– Cryptococcal meningitis – treatment of choice is amphotericin B plus 5-FC followed by fluconazole
High yield
• Latent TB diagnostics
– Prior BCG should not influence how you read PPD
– Interferon gamma release assays (IGRAs)– no false positives with prior BCG
– If + PPD or +IGRA, check chest X-ray and history to evaluate for active TB
• Active TB
– Treatment of active TB in HIV often use rifabutin not rifampin due to interactions with ARVs